Exposure to air pollution is a major contributor to the development and exacerbation of breathing disorders, affecting populations across all age groups and geographic regions. Air pollution and breathing disorders are closely linked, with pollutants such as particulate matter, ozone, nitrogen dioxide, and volatile organic compounds triggering inflammatory responses in the respiratory system, impairing lung function, and increasing susceptibility to infections. Long-term exposure can lead to chronic conditions, including asthma, chronic obstructive pulmonary disease, and interstitial lung disease, while acute exposure may provoke exacerbations and respiratory distress. Vulnerable populations, such as children, the elderly, and individuals with pre-existing respiratory or cardiovascular conditions, are particularly at risk. Addressing this challenge requires a combination of public health policies, environmental monitoring, and community education to reduce pollutant exposure and raise awareness about respiratory risks. Clinical strategies include early diagnosis, management of pollutant-induced symptoms, and personalized care plans that consider environmental triggers. Research continues to explore the biological mechanisms through which air pollution affects lung tissue, aiming to develop targeted interventions and preventive measures. Additionally, technological solutions such as air quality sensors, urban planning to minimize exposure, and patient guidance on protective behaviors are increasingly integrated into respiratory care. By understanding the impact of environmental pollutants on respiratory health and implementing coordinated mitigation strategies, healthcare providers can reduce the burden of breathing disorders and enhance long-term lung health at both individual and population levels.
Title : Novel signaling mechanisms and innovative therapeutic strategies of pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Susceptibility to SARS-CoV-2 infection and nasal air conditioning ability
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Comparative evaluation of DECAF and BAP 65 scores in predicting outcomes of COPD exacerbations among in patients at Vicente Sotto Memorial Medical Center
Allanys Joy Q Pino, Vicente Sotto Memorial Medical Center, Philippines
Title :
Saurabh Chattopadhyay, University of Kentucky College of Medicine, United States
Title : Personalized and precision Medicine (PPM) as a unique healthcare model through biodesign driven and inspired biotech, translational applications and pulmonology related marketing to secure the human healthcare, wellness and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation